These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19252280)

  • 1. Yokukansan inhibits social isolation-induced aggression and methamphetamine-induced hyperlocomotion in rodents.
    Uchida N; Egashira N; Iwasaki K; Ishibashi A; Tashiro R; Nogami A; Manome N; Abe M; Takasaki K; Mishima K; Takata J; Oishi R; Nishimura R; Fujiwara M
    Biol Pharm Bull; 2009 Mar; 32(3):372-5. PubMed ID: 19252280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex.
    Egashira N; Iwasaki K; Ishibashi A; Hayakawa K; Okuno R; Abe M; Uchida N; Mishima K; Takasaki K; Nishimura R; Oishi R; Fujiwara M
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1516-20. PubMed ID: 18558456
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effect of Yokukansan on social isolation-induced aggressive behavior of zinc-deficient and pair-fed mice.
    Takeda A; Iwaki H; Ide K; Tamano H; Oku N
    Brain Res Bull; 2012 Apr; 87(6):551-5. PubMed ID: 22373913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involvement of the benzodiazepine system in the anxiolytic-like effect of Yokukansan (Yi-gan san).
    Kamei J; Miyata S; Ohsawa M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1431-7. PubMed ID: 19647028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Yokukansan and Yokukansankachimpihange on Aggressive Behavior, 5-HT Receptors and Arginine Vasopressin Expression in Social Isolation-Reared Mice.
    Iba H; Watanabe T; Matsuzawa K; Saimiya M; Tanaka M; Nagao M; Moriyama H; Kubota K; Katsurabayashi S; Iwasaki K
    Biol Pharm Bull; 2019; 42(12):2009-2015. PubMed ID: 31787717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuropharmacological efficacy of the traditional Japanese Kampo medicine yokukansan and its active ingredients.
    Ikarashi Y; Mizoguchi K
    Pharmacol Ther; 2016 Oct; 166():84-95. PubMed ID: 27373856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized double-blind placebo-controlled multicenter trial of Yokukansan for neuropsychiatric symptoms in Alzheimer's disease.
    Furukawa K; Tomita N; Uematsu D; Okahara K; Shimada H; Ikeda M; Matsui T; Kozaki K; Fujii M; Ogawa T; Umegaki H; Urakami K; Nomura H; Kobayashi N; Nakanishi A; Washimi Y; Yonezawa H; Takahashi S; Kubota M; Wakutani Y; Ito D; Sasaki T; Matsubara E; Une K; Ishiki A; Yahagi Y; Shoji M; Sato H; Terayama Y; Kuzuya M; Araki N; Kodama M; Yamaguchi T; Arai H
    Geriatr Gerontol Int; 2017 Feb; 17(2):211-218. PubMed ID: 26711658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daily administration of yokukansan and keishito prevents social isolation-induced behavioral abnormalities and down-regulation of phosphorylation of neuroplasticity-related signaling molecules in mice.
    Fujiwara H; Han Y; Ebihara K; Awale S; Araki R; Yabe T; Matsumoto K
    BMC Complement Altern Med; 2017 Apr; 17(1):195. PubMed ID: 28376888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Yokukansan on behavioral and psychological symptoms of dementia in regular treatment for Alzheimer's disease.
    Okahara K; Ishida Y; Hayashi Y; Inoue T; Tsuruta K; Takeuchi K; Yoshimuta H; Kiue K; Ninomiya Y; Kawano J; Yoshida K; Noda S; Tomita S; Fujimoto M; Hosomi J; Mitsuyama Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Apr; 34(3):532-6. PubMed ID: 20170698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of yokukansan, a traditional Japanese medicine, on social and aggressive behaviour of para-chloroamphetamine-injected rats.
    Kanno H; Sekiguchi K; Yamaguchi T; Terawaki K; Yuzurihara M; Kase Y; Ikarashi Y
    J Pharm Pharmacol; 2009 Sep; 61(9):1249-56. PubMed ID: 19703376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of yokukansan on the behavioral and psychological symptoms of dementia in elderly patients with Alzheimer's disease.
    Monji A; Takita M; Samejima T; Takaishi T; Hashimoto K; Matsunaga H; Oda M; Sumida Y; Mizoguchi Y; Kato T; Horikawa H; Kanba S
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):308-11. PubMed ID: 19138715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of Yokukansan inhibits the development of atopic dermatitis-like lesions in isolated NC/Nga mice.
    Jiang J; Yamaguchi T; Funakushi N; Kuhara T; Fan PS; Ueki R; Suto H; Kase Y; Ikeda S; Ogawa H
    J Dermatol Sci; 2009 Oct; 56(1):37-42. PubMed ID: 19647983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Yokukansan, a Herbal Medicine in Japan, Buffers Social Crowding Stress via Ameliorating Glucocorticoid Secretion Response to Vasopressin.
    Tamano H; Morioka H; Iwaki H; Suzuki H; Sato Y; Takeda A
    Biol Pharm Bull; 2018; 41(6):920-924. PubMed ID: 29863081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice.
    Yamada M; Hayashida M; Zhao Q; Shibahara N; Tanaka K; Miyata T; Matsumoto K
    J Ethnopharmacol; 2011 Jun; 135(3):737-46. PubMed ID: 21513784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in delusions and hallucinations in patients with dementia with Lewy bodies upon administration of yokukansan, a traditional Japanese medicine.
    Iwasaki K; Kosaka K; Mori H; Okitsu R; Furukawa K; Manabe Y; Yoshita M; Kanamori A; Ito N; Wada K; Kitayama M; Horiguchi J; Yamaguchi S; Takayama S; Fukuhara R; Ouma S; Nakano S; Hashimoto M; Kinoshita T
    Psychogeriatrics; 2012 Dec; 12(4):235-41. PubMed ID: 23279145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kampo formulations, chotosan, and yokukansan, for dementia therapy: existing clinical and preclinical evidence.
    Matsumoto K; Zhao Q; Niu Y; Fujiwara H; Tanaka K; Sasaki-Hamada S; Oka J
    J Pharmacol Sci; 2013; 122(4):257-69. PubMed ID: 23883485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress.
    Yamaguchi T; Tsujimatsu A; Kumamoto H; Izumi T; Ohmura Y; Yoshida T; Yoshioka M
    J Ethnopharmacol; 2012 Sep; 143(2):533-9. PubMed ID: 22819689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Yokukansan, a Traditional Japanese Medicine, Enhances the L-DOPA-Induced Rotational Response in 6-Hydroxydopamine-Lesioned Rats: Possible Inhibition of COMT.
    Ishida Y; Ebihara K; Tabuchi M; Imamura S; Sekiguchi K; Mizoguchi K; Kase Y; Koganemaru G; Abe H; Ikarashi Y
    Biol Pharm Bull; 2016; 39(1):104-13. PubMed ID: 26725433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yokukansan in the Treatment of Behavioral and Psychological Symptoms of Dementia: An Updated Meta-Analysis of Randomized Controlled Trials.
    Matsunaga S; Kishi T; Iwata N
    J Alzheimers Dis; 2016 Sep; 54(2):635-43. PubMed ID: 27497482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple Psychopharmacological Effects of the Traditional Japanese Kampo Medicine Yokukansan, and the Brain Regions it Affects.
    Mizoguchi K; Ikarashi Y
    Front Pharmacol; 2017; 8():149. PubMed ID: 28377723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.